Alessandra Bearz

18PUBLICATIONS
83CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 26, 2026
Probe-Based Confocal Laser Endomicroscopy During Immune Checkpoint Inhibitor Therapy: A Translational Framework Linking Intestinal Barrier Function, Microbiota, and Clinical Outcomes.

|Apr 27, 2026
Cost-effectiveness analysis of lorlatinib as first-line treatment for anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer in Italy.

|Apr 08, 2026
Lorlatinib in patients with ALK-positive metastatic NSCLC previously treated with an ALK inhibitor: results from a phase IV study.

Alessandra Bearz, Serena Ricciardi, Nirmal Vivek Raut

|Sep 09, 2025
Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B).

James Chih-Hsin Yang, Mengzhao Wang, Ludovic Doucet

|May 14, 2025
Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor (EGFR) Common Mutations: New Strategies.

Brigida Stanzione, Alessandro Del Conte, Elisa Bertoli

|Jan 25, 2025
Immunotherapy in Oncogene-Addicted NSCLC: Evidence and Therapeutic Approaches.

Lorenzo Foffano, Elisa Bertoli, Martina Bortolot

Pageof 3

Frequent Collaborators

9 joint publications

Brigida Stanzione

8 joint publications

Alessandro Del Conte

6 joint publications

Elisa Bertoli

5 joint publications

Sara Torresan